Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase I/II, Multi-Center, Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT00862082 is registered in ClinicalTrials.gov with Proacta, Incorporated as lead sponsor.

NCT NCT00862082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00862082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase I/II, Multi-Center, Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Lead sponsor
Proacta, Incorporated
Phase
Phase 1/2
Overall status
Terminated
Start date
March 31, 2009
Completion date
May 31, 2010
Enrollment
14 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma